Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





CHLORINE DIOXIDE								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 10049-04-4; **Chemical Formula:** ClO2
Previously, OSHA had an 8-hour TWA limit of 0.1 ppm for chlorine dioxide. The ACGIH recommends the same time-weighted average and a 15-minute STEL of 0.3 ppm. The proposal retained the same TWA and added a 15-minute STEL of 0.3 ppm, and NIOSH (Ex. 8-47, Table N1) concurred with these limits, which are established in the final rule. Chlorine dioxide is a red-yellow gas at ordinary temperatures.
Rats exposed to 0.1-ppm concentrations of chlorine dioxide for 10 weeks at five hours daily showed no adverse effects from exposures. Other data in animals are not available (Dalhamn 1957/Ex. 1-307).
Data on human exposures indicate that marked irritation occurs on inhalation of 5 ppm (no time specified), and that one death occurred at 19 ppm (Elkins 1959b, as cited in ACGIH 1986/Ex. 1-3, p. 118). Repeated exposures in humans have been linked to bronchitis and pronounced emphysema (Petry 1954/Ex. 1-1163). Clinical studies conducted by Gloemme and Lundgren (1957/Ex. 1-323) revealed that the majority of workers who had been exposed for five years to average concentrations of chlorine dioxide below 0.1 ppm, in combination with about 1.0 ppm chlorine, experienced eye and respiratory irritation and slight bronchitis. Some gastrointestinal irritation was also observed in these workers. Gloemme and Lundgren (1957/Ex. 1-323) attributed all of these effects to elevated short-term exposures involving excursions above the 0.1 ppm level. Ferris, Burgess, and Worcester (1967/Ex. 1-316) have shown that concentrations occasionally ranging as high as 0.25 ppm were associated with respiratory effects in workers concomitantly exposed to chlorine. The United Paperworkers International Union (UPIU) supported the development of comprehensive standards for irritant gases such as chlorine dioxide.
In the final rule, OSHA is retaining the 0.1-ppm 8-hour TWA and adding a 15-minute STEL of 0.3 ppm for chlorine dioxide. The Agency concludes that both of these limits are necessary to protect workers against the significant risk of respiratory, skin, and eye irritation known to occur as a result of short-term exposures above the TWA of 0.1 ppm. OSHA has determined that these adverse effects constitute material impairments of health.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue